{"id":976454,"date":"2026-06-29T08:43:59","date_gmt":"2026-06-29T12:43:59","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/"},"modified":"2026-06-29T08:43:59","modified_gmt":"2026-06-29T12:43:59","slug":"dyadic-expands-ip-protection-and-business-development-activities-in-japan","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/","title":{"rendered":"Dyadic Expands IP Protection and Business Development Activities in Japan"},"content":{"rendered":"<h2>\nBolsters Japan Market Expansion, Strategic Collaborations and Demand for Scalable Recombinant Protein Solutions<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>JUPITER, Fla., June  29, 2026  (GLOBE NEWSWIRE) &#8212; Dyadic International, Inc. (Nasdaq: DYAI) (\u201cDyadic\u201d or the \u201cCompany\u201d), d\/b\/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial protein production platforms for use across life sciences, food, nutrition, industrial, and biopharmaceutical sectors, today announced that the Japan Patent Office has allowed claims covering its proprietary <em>Thermothelomyces heterothallica<\/em>\u00a0recombinant protein expression technology.<\/p>\n<p>The Japan Patent Office allowed claims covering novel aspects of Dyadic\u2019s proprietary <em>Thermothelomyces heterothallica<\/em> recombinant protein expression technology. This milestone adds significant protection to the Company\u2019s expanding global intellectual property portfolio and reinforces the strength of Dyadic\u2019s differentiated C1 and Dapibus\u2122 microbial production platforms.<\/p>\n<p>\u201cThis patent represents an important milestone in our strategy to expand Dyadic\u2019s intellectual property position and commercial opportunities in one of the world\u2019s most advanced biotechnology markets,\u201d said Joe Hazelton, Dyadic\u2019s President and Chief Operating Officer.<\/p>\n<p>As part of its international growth strategy, Dyadic engaged Intralink, a leading international business development and market expansion firm, to support expansion efforts in Japan and other key markets. These efforts have generated targeted engagement opportunities with prospective partners, customers, and collaborators across the biotechnology, pharmaceutical, food, nutrition, life sciences, cosmetics, and industrial sectors. Mr. Hazelton is scheduled to meet with several high-potential existing and prospective partners during a business development visit in early July.<\/p>\n<p>Japan is a strategic market for Dyadic, recognized for its leadership in regenerative medicine, biologics manufacturing, precision fermentation, advanced bioprocessing, biopharmaceuticals, cosmetics, food and nutrition technologies, and life sciences innovation. The Company believes its enhanced intellectual property protection, Intralink\u2019s local business development support, and planned in-country engagements position Dyadic to capitalize on growing demand for scalable recombinant protein solutions.<\/p>\n<p>\u201cAs we continue transforming Dyadic into a recombinant protein solutions company, expanding our presence in key global biotechnology markets is an important component of our long-term growth strategy,\u201d added Mr. Hazelton. \u201cOur collaboration with Intralink has accelerated business development efforts in Japan and helped establish meaningful discussions with organizations seeking flexible, scalable, and cost-effective protein production solutions.\u201d<\/p>\n<p>Dyadic\u2019s proprietary C1 and Dapibus\u2122 expression platforms are designed to enable rapid, scalable, and cost-effective production of recombinant proteins across multiple high-growth markets. Through commercial products, technology licensing, custom development, and strategic collaborations, the Company supports customers developing applications ranging from life sciences, food and nutrition, cosmetics to industrial enzymes, vaccines, monoclonal antibodies, and other biologics.<\/p>\n<p>Dyadic believes its strengthened intellectual property portfolio, expanding commercial capabilities, growing network of strategic partners, and increasing international business development activities position the Company to address rising growing global demand for recombinant protein and support its long-term growth strategy.<\/p>\n<p>\n        <strong>About Dyadic Applied BioSolutions<\/strong>\n      <\/p>\n<p>Dyadic Applied BioSolutions is a global biotechnology company that aims to develop and commercialize scalable, non-animal protein production platforms to meet growing global demand across the life sciences, food and nutrition, and bio-industrial markets. These high-value proteins are designed to enable customers to develop more efficient, scalable, and sustainable products. Dyadic\u2019s proprietary Dapibus\u2122 and C1 expression systems support rapid, cost-effective, and flexible manufacturing.<\/p>\n<p>For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=JhnDcIFViom5WwpVO63D92RcjQiMpcXlRqAEOEd6yeY7uxYnG-yZt2dHmdKsk_N5-cM8F8mRVrB-fQNEQw9E-Z2L90bHkqiHQg61iDOaC4I=\" rel=\"nofollow\" target=\"_blank\"><strong>http:\/\/www.dyadic.com<\/strong><\/a>.<\/p>\n<p>\n        <strong>Safe Harbor Regarding Forward-Looking Statements<\/strong>\n      <\/p>\n<p>This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, including those regarding Dyadic International\u2019s expectations, intentions, strategies, and beliefs pertaining to future events or future financial performance, such as the success of our clinical trial and interest in our protein production platforms, our research projects and third-party collaborations, as well as the availability of necessary funding. Forward-looking statements generally can be identified by use of the words \u201cexpect,\u201d \u201cshould,\u201d \u201cintend,\u201d \u201canticipate,\u201d \u201cwill,\u201d \u201cproject,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201cpotential,\u201d or \u201ccontinue\u201d and other similar terms or variations of them or similar terminology. Dyadic International, Inc., and its subsidiaries caution readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information. Such statements reflect the current views of our management with respect to our operations, results of operations and future financial performance. Forward-looking statements involve many risks, uncertainties, or other factors beyond Dyadic\u2019s control. These factors include, but are not limited to (i) our history of net losses; (ii) market and regulatory acceptance of our microbial protein production platforms and other technologies; (iii) failure to commercialize our microbial protein production platforms or our other technologies; (iv) competition, including from alternative technologies; (v) the results of nonclinical studies and clinical trials; (vi) our capital needs; (vii) changes in global economic and financial conditions; (viii) our reliance on information technology; (ix) our dependence on third parties; (x) government regulations and environmental, social and governance issues; (xi) intellectual property risks; (xii) our ability to comply with the listing standards of the Nasdaq Stock Market LLC; and (xii) other factors discussed in Dyadic\u2019s publicly available filings, including information set forth under the caption \u201cRisk Factors\u201d in Dyadic\u2019s annual report on Form 10-K filed with the Securities and Exchange Commission (\u201cSEC\u201d) on March 25, 2026, as amended on April 30, 2026, and quarterly report on Form 10-Q filed with the SEC on May 13, 2026, as such factors may be updated from time to time in Dyadic\u2019s periodic filings with the SEC, which are accessible on the SEC\u2019s website and at www.dyadic.com. The forward-looking statements contained in this press release are made only as of the date hereof, and except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.<\/p>\n<p>\n        <strong>Media contacts:<\/strong>\n      <\/p>\n<p>Dyadic Applied BioSolutions:<br \/>Ping Rawson<br \/>Chief Financial Officer<br \/>Phone: (561) 743-8333<br \/>Email:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MZ8bJyuRNpEDFIX6DMjQazY3j-4swoASuuRmls96CdL-thyyHZsS2wa97vohToMilje20A2EW33vqTXdogsl4g==\" rel=\"nofollow\" target=\"_blank\"><strong>ir@dyadic.com<\/strong><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/Y2IyMDg1OWItM2MzNS00NjM3LTg5OWQtOTJmN2IxNWFlZDQ0LTEwMzA3ODMtMjAyNi0wNi0yOS1lbg==\/tiny\/Dyadic-International-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Bolsters Japan Market Expansion, Strategic Collaborations and Demand for Scalable Recombinant Protein Solutions JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) &#8212; Dyadic International, Inc. (Nasdaq: DYAI) (\u201cDyadic\u201d or the \u201cCompany\u201d), d\/b\/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial protein production platforms for use across life sciences, food, nutrition, industrial, and biopharmaceutical sectors, today announced that the Japan Patent Office has allowed claims covering its proprietary Thermothelomyces heterothallica\u00a0recombinant protein expression technology. The Japan Patent Office allowed claims covering novel aspects of Dyadic\u2019s proprietary Thermothelomyces heterothallica recombinant protein expression technology. This milestone adds significant protection to the Company\u2019s expanding global intellectual property portfolio and reinforces the strength of Dyadic\u2019s differentiated C1 and Dapibus\u2122 microbial &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Dyadic Expands IP Protection and Business Development Activities in Japan&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-976454","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Bolsters Japan Market Expansion, Strategic Collaborations and Demand for Scalable Recombinant Protein Solutions JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) &#8212; Dyadic International, Inc. (Nasdaq: DYAI) (\u201cDyadic\u201d or the \u201cCompany\u201d), d\/b\/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial protein production platforms for use across life sciences, food, nutrition, industrial, and biopharmaceutical sectors, today announced that the Japan Patent Office has allowed claims covering its proprietary Thermothelomyces heterothallica\u00a0recombinant protein expression technology. The Japan Patent Office allowed claims covering novel aspects of Dyadic\u2019s proprietary Thermothelomyces heterothallica recombinant protein expression technology. This milestone adds significant protection to the Company\u2019s expanding global intellectual property portfolio and reinforces the strength of Dyadic\u2019s differentiated C1 and Dapibus\u2122 microbial &hellip; Continue reading &quot;Dyadic Expands IP Protection and Business Development Activities in Japan&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T12:43:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Dyadic Expands IP Protection and Business Development Activities in Japan\",\"datePublished\":\"2026-06-29T12:43:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/\"},\"wordCount\":978,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/\",\"name\":\"Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\",\"datePublished\":\"2026-06-29T12:43:59+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dyadic Expands IP Protection and Business Development Activities in Japan\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/","og_locale":"en_US","og_type":"article","og_title":"Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk","og_description":"Bolsters Japan Market Expansion, Strategic Collaborations and Demand for Scalable Recombinant Protein Solutions JUPITER, Fla., June 29, 2026 (GLOBE NEWSWIRE) &#8212; Dyadic International, Inc. (Nasdaq: DYAI) (\u201cDyadic\u201d or the \u201cCompany\u201d), d\/b\/a Dyadic Applied BioSolutions, a biotechnology company focused on the development and commercialization of scalable microbial protein production platforms for use across life sciences, food, nutrition, industrial, and biopharmaceutical sectors, today announced that the Japan Patent Office has allowed claims covering its proprietary Thermothelomyces heterothallica\u00a0recombinant protein expression technology. The Japan Patent Office allowed claims covering novel aspects of Dyadic\u2019s proprietary Thermothelomyces heterothallica recombinant protein expression technology. This milestone adds significant protection to the Company\u2019s expanding global intellectual property portfolio and reinforces the strength of Dyadic\u2019s differentiated C1 and Dapibus\u2122 microbial &hellip; Continue reading \"Dyadic Expands IP Protection and Business Development Activities in Japan\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-29T12:43:59+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Dyadic Expands IP Protection and Business Development Activities in Japan","datePublished":"2026-06-29T12:43:59+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/"},"wordCount":978,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/","name":"Dyadic Expands IP Protection and Business Development Activities in Japan - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=","datePublished":"2026-06-29T12:43:59+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1Mzg2OSM3NjgxOTg4IzIwMTkyMTA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/dyadic-expands-ip-protection-and-business-development-activities-in-japan\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Dyadic Expands IP Protection and Business Development Activities in Japan"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/976454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=976454"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/976454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=976454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=976454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=976454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}